Topic: Emergent BioSolutions Inc.

Emergent BioSolutions purchase of Trubion Pharma clears regulatory hurdle earlyThe planned buyout of Trubion Pharmaceuticals Inc. by Emergent BioSolutions Inc. cleared a regulatory hurdle Wednesday, bringing the deal, potentially worth $135.5 million, closer to closing.The Department of Justice and Federal Trade Commission ...